Microbiology Spectrum · 2022 · 20 citations · 26 references
Life SciencesInfectious DiseasesPharmacotherapyAntimicrobial ResistanceAntimicrobial StewardshipMedical MicrobiologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsCarbapenem ResistanceCombination Antimicrobial TherapyAntibiotic CombinationsAntimicrobial Resistance MitigationCarbapenem Resistance MechanismsColistin Resistance MechanismsInfection Risk FactorsKlebsiella Pneumoniae CarbapenemaseKlebsiella Pneumoniae ResistanceNovel Antibacterial Agents
Treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections is challenging due to the limited options of antibiotics. Colistin is one of the last-resort antibiotics if novel antimicrobial agents are not available. It is crucial to identify modifiable clinical factors associated with the emergence of resistance during colistin treatment. Here, we found that the addition of tigecycline to colistin treatment prevented the acquisition of colistin resistance. Colistin-tigecycline combination therapy is therefore considered a hopeful option in antimicrobial stewardship to treat CRKP infections.
26
Performance standards for antimicrobial susceptibility testing
Mary Jane Ferraro · 2001 · 9.8K citations
Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fábio Madeira, Young Mi Park, Joon Lee et al. · Nucleic Acids Research · 2019 · 4.7K citations · Full text
ISfinder: the reference centre for bacterial insertion sequences
Patricia Siguier · Nucleic Acids Research · 2005 · 2.8K citations · Full text
Mario Tumbarello, Pierluigi Viale, Claudio Viscoli et al. · Clinical Infectious Diseases · 2012 · 1K citations